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Ginkgolic acid C15:1 (1) and ginkgolic acid C15:0 (2) are 
natural acids isolated from Ginkgo biloba (Figure 1).1 
Ginkgolic acid is a component of a botanical extract which 
shows pleiotropic effects including antitumor and anti-HIV 
activities.2 The synthesis of (1) has been reported by Martin 
in 2018 using a Heck-based strategy.3 Several researchers 
used Wittig-based strategies.4-7 The lateral alkylation strategy 
presented herein, also used by Tyman,8 utilizes commercially 
available and stable reagents such as (3) and is amenable to 
scale up.
Protection of 6-methyl salicylic acid (3) with in situ derived 
chloromethyl methyl ether provided ester (4) as shown in 
Scheme 1.9 A variety of bases were evaluated for the deproton-
ation of (4). Ultimately, treatment of (4) with lithium 
2,2,6,6-tetramethylpiperidine (LiTMP) in tetrahydrofuran 
(THF) at −78°C, followed by the addition of the acetylenic 
iodide (5),10 and warming to ambient temperature overnight 
afforded the alkynyl ester (6) in 60% yield. Reduction of the 
alkyne using hydrogen and the Lindlar’s catalyst followed by 
treatment with 1 N HCl to remove the protecting groups 
afforded (1) in 61% yield. The use of the methoxy methyl ether 
protecting groups increased the solubility of 4 and enables easy 
global deprotection to 1.
The reaction of the anion of (4) with 1-iodotetradecane 
followed by deprotection generated (2) in 61% yield as 
shown in Scheme 2. Iodotetradecane was prepared from the 
commercially available chloride in 90% yield using sodium 
iodide.
The synthesis of (1) and (2) in three or four steps consti-
tutes a direct route to these biologically active compounds.11 
This direct pathway will enable the synthesis of (1), (2), and 
analogs for biological evaluation.
Experimental
Methoxymethyl 2-(Methoxymethoxy)-6-
Methylbenzoate (4)
To 35 mL DMF was added (3) (893 mg, 5.86 mmol) and 
allowed to stir at 0°C for 15 minutes. Then 5 equivalents of 
NaH was added in 4 portions. The solution was brought from 
0°C to r.t for 30 minutes, then cooled back to 0°C. 
Chloromethyl methyl ether, (1.4 mL, 3.14 equiv.), was added 
over 4 additions, every 15 to 20 minutes. Reaction was gen-
tly quenched with ice and sat. NH4Cl and then extracted with 
ethyl acetate. After drying over Na2SO4, and concentrating 
in vacuo, the resulting oil was purified using silica gel chro-
matography (Hexane:Ethyl acetate, 3:7) affording a clear, 
colorless, oil (4) (1.13 g, 80% yield).
1H NMR (400 MHz CDCl3): δ (ppm) 7.23 (t, J = 8.0 Hz, 
1H), 6.99 (d, J = 8.4 Hz, 1H), 6.87 (d, J = 7.6 Hz, 1H), 5.47 
(s, 2H), 5.18 (s, 2H), 3.56 (s, 3H), 3.47 (s, 3H), δ 2.34 (s, 
3H).
Methoxymethyl-2-(Methoxymethoxy)-6-(Pentadec-8-
yn-1-yl) Benzoate (6)
To oven dried reaction vessel tetramethylpiperidine (0.26 
mL, 1.5 mmol) was added, followed by 6 mL of THF and 
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was cooled to 0°C. Argon was then bubbled through the 
solution for ~5 minutes. Addition of nBuLi (0.60 mL, 1.5 
mmol) was done dropwise, and the reaction allowed to 
reach room temperature (r.t.) for 25 minutes. The solution 
was then cooled to −78°C where (4) (238 mg, 0.991 mmol) 
in 2 mL of THF was slowly added and reacted for 71 min-
utes. Then (5) (548 mg, 1.7 mmol) in 2 mL of THF was 
chilled to −78°C, and syringed while cold. The reaction 
was let warm to room temperature overnight. The reaction 
was quenched with sat. NH4Cl and extracted with ethyl 
acetate, dried over Na2SO4, and concentrated in vacuo. 
The resulting oil was purified using silica gel chromatog-
raphy (Hexane:Ethyl acetate, 1:1) affording a clear, orange, 
oil (6) (0.260 g, 60% yield).
1H NMR (400 MHz CDCl3): δ (ppm) 7.26 (t, J = 7.9 Hz, 
1H), 7.00 (d, J = 8.1 Hz , 1H), 6.89 (d, , J = 7.7 Hz, 1H), 5.46 
(s, 2H), 5.18 (s, 2H), 3.56 (s, 3H), 3.47 (s, 3H), 2.59 (t, J = 
7.8 Hz, 2H), 2.13 (m, 4H), 1.60 (m, 4H), 1.51-1.22 (m, 16H), 
0.88 (t, J = 6.5 Hz, 3H).
(Z)-2-Hydroxy-6-(Pentadec-8-en-1-yl)Benzoic acid (1)
A flask containing (6) (208 mg, 0.48 mmol), in 5 mL of 
methanol, with 10 µL of quinoline, was sparged with 
Argon. Lindlar’s catalyst was added, and then hydrogen 
was bubbled through via balloon. Lindlar’s catalyst was 
removed over a pad of Celite, and the filtrate condensed. 
Treatment of the resulting oil with 1 M HCl in the presence 
of isopropyl alcohol for 5 hours afforded (1) (0.101 g, 61% 
yield).
1H NMR (400 MHz CDCl3): δ (ppm) 7.09 (t, J = 7.8 Hz, 
1H), 6.67 (d, J = 8.1 Hz, 1H), 6.62 (d, 1H, J = 7.5 Hz), 5.32 
(m, 2H), 2.95 (t, J = 7.5 Hz, 2H), 1.96 (m, 4H), 1.50 (m, 2H), 
1.32-1.18 (m, 17H), 0.84 (t, J = 6.6 Hz, 3H).
LRMS (ESI-QTOF) calcd. for C22H34O3 [M-H]
− 
345.2435, found 345.2445.
2-Hydroxy-6-Pentadecylbenzoic Acid (2)
To an oven dried flask tetramethylpiperidine (0.34 mL, 2.0 
mmol) was added, followed by 2 mL of THF and was cooled 
to 0°C. Argon was then bubbled through the solution for ~5 
minutes. Addition of nBuLi, (0.80 mL, 2.0 mmol) was done 
dropwise, and the flask allowed to reach r.t. for 26 minutes. 
It was then cooled to −78°C where (4) (291 mg, 1.21 mmol) 
in 2 mL of THF was slowly added and reacted for 70 min-
utes. 1-Iodotetradecane (778 mg, 2.4 mmol) in 2 mL of THF, 
was chilled to −78°C, and syringed while cold. The reaction 
was let warm to room temperature overnight. The reaction 
was acidified with 1 M HCl in the presence of isopropyl 
alcohol for 5 hours and extracted with ethyl acetate, dried 
over Na2SO4, and then concentrated in vacuo. The resulting 
solid was purified using silica gel chromatography 
(Hexane:Ethyl acetate, 1:1) affording a brownish orange 
solid (2) (0.257 g, 61% yield).
1H NMR (400 MHz CDCl3): δ (ppm) 11.12 (s, OH), 7.29 
(t, J = 8.2 Hz, 1H), 6.84 (d, J = 8.2 Hz, 1H), 6.72, (d, J = 7.6 
Hz, 1H), 2.88 (t, J = 7.5 Hz, 2H), 1.53-1.15 (m, 26H), 0.88 
(t, J = 7.5 Hz, 3H).
1-Iodotetradecane
To an oven dried flask 1-chlorotetradecane (2.35 g, 14.4 
mmol) was added, followed by 50 mL of acetone and NaI 
(3.01 g, 20.1 mmol), and refluxed for 48 hours. Then the 
reaction was cooled to 0°C and extracted with hexane and 
concentrated in vacuo. Residual yellow discoloration was 
removed over a pad of silica affording a clear, colorless, oil 
(4.20 g, 90% yield).
1H NMR (400 MHz CDCl3): δ (ppm) 3.18 (t, J = 7.1 Hz, 
2H), 1.82 (pent, J = 7.2 Hz, 2H), 1.43-1.21 (m, 22H), 0.88 (t, 
J = 6.8 Hz, 3H).
Figure 1. Structures for ginkgolic acids C15:1 (1) and C15:0 (2).
Scheme 1.  Synthesis of 1.
Scheme 2.  Synthesis of (2).
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